Trial
NCT03330834
CAR-T Cell Immunotherapy for Advanced Lung Cancer
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
Sun Yat-sen University
Collaborators
Guangzhou Yiyang Biological Technology Co., Ltd.
Condition
Advanced Lung Cancer
Intervention
CAR-T cells to treat advanced lung cancer
Why stopped
Serious adverse events
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-07-13